Highest-materiality recent filing
Ryan Specialty boosts buyback authorization by $300M to $600M total
Board increased share repurchase program by $300M on May 21, 2026; total authorization now $600M.
Ryan Specialty Q1 revenue up 15.2%; net income $40.6M vs prior-year loss
Total revenue $795.2M (+15.2% YoY); organic growth 11.8%, down from 12.9% prior-year.
Q4 revenue $751.2M (+13.2% YoY); organic growth 6.6% vs 11.0% prior year.
Ryan Specialty Q3 revenue up 24.8% to $754.6M, organic +15.0%, net income $62.6M
Total revenue $754.6M, +24.8% YoY; organic growth 15.0% (vs 11.8% prior-year).
Ryan Specialty appoints Keogh and Mulshine as Co-Presidents; Bickham advisor
Stephen P. Keogh named Co-President and COO; Brendan M. Mulshine named Co-President and CRO.
Ryan Specialty Q2 total revenue $855.2M, +23% YoY; Adj. EPS $0.66, +13.8%; declares $0.12 dividend
Total revenue $855.2M (+23.0% YoY); organic revenue growth 7.1% decelerated from 14.2%.
Ryan Specialty board lead director Cam Findlay dies; successors named
D. Cameron Findlay, board member since 2012 and Lead Director, passed away unexpectedly in July 2025.
Ryan Specialty stockholders approve governance overhaul including Class B vote sunset by Sept 2029
Stockholders approved declassification of Board and phase-in of annual director elections; four nominees elected to three-year terms expiring 2028.
Ryan Specialty Q1 rev up 25% to $690M; GAAP net loss $4.4M; declares $0.12 dividend
Total revenue $690.2M (+25% YoY); organic growth 12.9%.
Ryan Specialty Q4 revenue up 24.5% to $663.5M; Adj. EBITDAC +36.2%; declares $0.12 dividend
Total revenue $663.5M (+24.5% YoY); organic growth 11.0% (vs 16.5% prior year).
Ryan Specialty Issues $600 Million Additional 5.875% Senior Secured Notes Due 2032
Issued $600M aggregate principal amount of additional 5.875% Senior Secured Notes due 2032 on Dec 9, 2024.
Ryan Specialty launches $500M add-on to 5.875% senior secured notes due 2032
Up to $500M aggregate principal of additional 5.875% senior secured notes due 2032 in a private offering.
Ryan Specialty upsizes and prices $600M of 5.875% senior secured notes due 2032
Offering increased by $100M from previously announced $500M; priced at 99.5% of par.
Ryan Specialty Q3 revenue up 20.5% to $604.7M; adj. EPS $0.41 beats prior year by 28%
Total revenue $604.7M (+20.5% YoY); organic revenue growth 11.8% (vs 15.0% prior year).
Ryan Specialty refinances $1.588B term loan, issues $600M 5.875% notes due 2032
Refinanced existing $1.5881B term loan; added $111.875M incremental term loan at SOFR+2.25% (down 50 bps).
Ryan Specialty upsizes and prices $600M Senior Secured Notes at 5.875% due 2032
Priced $600M aggregate principal of 5.875% Senior Secured Notes due 2032 at 100% of par.
Ryan Specialty completes acquisition of US Assure for $1.075B cash plus up to $400M earnout
Acquisition closed Aug 30 for $1.075B cash plus up to $400M earnout based on performance targets.
Ryan Specialty Q2 revenue $695M (+18.8%), acquires US Assure, CEO succession
Revenue $695.4M (+18.8% YoY); organic growth 14.2%; Net income $118M ($0.37 diluted EPS).
Ryan Specialty to acquire US Assure for ~$1.075B plus up to $400M earnout
Acquisition of US Assure for $1.075B in cash plus up to $400M earnout based on 3-year performance targets.
Founder/Chairman/CEO Pat Ryan (age 87) transitions to Executive Chairman, continuing as executive officer.
Ryan Specialty Q1 revenue $552M (+20.6% YoY); adj. EPS $0.35 (+34.6%)
Total revenue $552.0M, up 20.6% YoY; organic revenue growth 13.7% vs. 13.4% prior year.
Ryan Specialty Q4 revenue $532.9M (+22.5% YoY); initiates $0.11 quarterly dividend
Total revenue $532.9M (+22.5% YoY); organic revenue growth 16.0% (vs 10.3% prior year).
Ryan Specialty Q3 revenue up 21.8% to $502M; adj. diluted EPS $0.32 beats prior year
Total revenue $501.9M, up 21.8% YoY; organic growth rate 14.7%.
Ryan Specialty reports Q2 2023 revenue up 19.1% to $585.1M; adjusted diluted EPS $0.45
Revenue $585.1M, +19.1% YoY; organic growth 16.1% (prior-year 22.3%).
Selling shareholders to sell 9M shares of Ryan Specialty at $43.45 in secondary offering
9,000,000 shares sold by selling shareholders at $43.45/share; company receives no proceeds.
Ryan Specialty Q1 revenue up 18.3% to $457.6M; net income doubles to $36.5M
Total revenue $457.6M (+18.3% YoY); organic growth 12.9%.
Board approved two-year restructuring program starting Q1 2023, expected to generate $35M annual cost savings by 2025.
Ryan Specialty Q2 revenue up 26% to $491M; organic growth 22.3%
Net income $70.1M ($0.22 diluted EPS); adjusted net income $106.4M ($0.39 adjusted EPS).
Ryan Specialty Q1 revenue up 24.2% to $386.9M; organic growth 20.1%
Net income of $18.1M ($0.06 diluted EPS) vs net loss of $3.8M a year ago.
Ryan Specialty Q4 total revenue $378.5M (+15.8%), net income $29.6M, adj. EPS $0.29
Total revenue $378.5M (+15.8% YoY); organic revenue growth 15.4%.
On March 27, 2025, Ryan Specialty Holdings, Inc. (the “Company”) announced the appointment of Mr. Stephen P. Keogh to the position of Chief Operating Officer of the Company, effective May 1, 2025.
and Janice M. Hamilton, Chief Accounting Officer, as Chief Financial Officer
Patrick G. Ryan, the Company’s Founder, Chairman, and Chief Executive Officer, will transition to the role of Executive Chairman
The succession plan also includes the appointment of Jeremiah R. Bickham, Chief Financial Officer, as President
Timothy W. Turner, President of Ryan Specialty and Chairman and CEO of Ryan Turner Specialty (“RT Specialty”), will become Chief Executive Officer
On December 28, 2023, William J. Devers informed the Board of Directors (the “Board”) of Ryan Specialty Holdings, Inc. (the “Company”) that he has decided to retire from service on the Board effective as of December 31, 2023.
On December 29, 2023, the Board elected Patrick G. Ryan, Jr. as a director, effective January 1, 2024.
elected Anthony J. Kuczinski as a director and assigned him to its Compensation and Governance Committee, effective immediately.
On July 31, 2023, the Board of Directors (the “Board”) of Ryan Specialty Holdings, Inc. (the “Company”), upon the recommendation of the Compensation and Governance Committee of the Board, elected Francesca Cornelli as a director and assigned her to its Audit Committee, effective immediately.
On March 9, 2023, Ryan Specialty Holdings, Inc. (the “Company”) announced that Michael T. VanAcker is moving from his position as Chief Operating Officer to Executive Vice President of RT Specialty, Ryan Specialty’s wholesale brokerage and binding authority specialty.
On July 21, 2021, Henry S. Bienen, David P. Bolger, Michelle L. Collins, Nicholas D. Cortezi, William J. Devers, D. Cameron Findlay, Robert Le Blanc, Andrew J. McKenna, Michael D. O’Halleran, John W. Rogers, Jr. and Timothy W. Turner were appointed to the Company’s board of directors.
On July 21, 2021, Henry S. Bienen, David P. Bolger, Michelle L. Collins, Nicholas D. Cortezi, William J. Devers, D. Cameron Findlay, Robert Le Blanc, Andrew J. McKenna, Michael D. O’Halleran, John W. Rogers, Jr. and Timothy W. Turner were appointed to the Company’s board of directors.
Max materiality 0.90 · Median 0.65 · Most common event earnings